Back to Dashboard
DR-01-ONC-001
Lymphoma
•
NCT05475925
•
Last updated: 2/17/2026
Recruiting
Study Design
Study Drug
DR-01
Mechanism of Action
human IgG1 antibody against CD94,
Sponsor
Unknown
Design
I/II
Control Arm
-
Criteria
Inclusion Criteria
≥1 prior Tx
Age: Phase: I/II
Exclusion Criteria
Enrollment
Progress
2 / 2
Contact Information
Principal Investigator
Unknown
Study Nurse
李佳玲
Contact Tel
4620